Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German G-BA looks to Bronner for the long-term

This article was originally published in Clinica

Executive Summary

Dorothea Bronner, the chief executive at the German joint federal committee (G-BA), has been reappointed to the post for a five-year period from January 2007 until the end of 2011. Dr Bonner was also head of the forerunner of the G-BA, the co-ordination committee working group. The G-BA decides on the reimbursement of healthcare products in Germany. The reinstated head has pledged to make transparency of the G-BA's work and decision-making a priority. The G-BA oversees IQWIG, its executive arm, which carries out the HTA function.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT058128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel